USPTO serial 97495357
WERFEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 25, 2024
- Examiner
- MAROTTA, GABRIELLE CHRISTINA
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with WERFEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Deborah J. Peckham
Deborah J. Peckham Barclay Damon LLP160 Federal Street, Suite 1001Boston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Clinical medical reagents; Diagnostic reagents for medicinal use; Immunoassay reagents for medical use; Chemical reagents for medical or veterinary purposes; Medical diagnostic reagents; Veterinary diagnostic reagents | ACTIVE | Jan 1, 2007 |
| 009 | Computers; Apparatus for broadcasting, recording, transmission or reproduction of sound or images; Data processing equipment; Recorded computer programs for database management for laboratory information systems, data management for specific clinical applications, data analysis for integrated communication solutions, data analysis for clinical diagnostics, data analysis for comprehensive solutions for patient-focused systems, clinical diagnosis and evaluation for therapy management, clinical diagnosis and evaluation for chronic disorders, and clinical diagnosis and evaluation for telemedicine | ACTIVE | Jan 1, 2007 |
| 010 | Medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of automated coagulation analyzers, namely, electronic instruments for measuring the characteristics and components of blood clots; medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of automated bodily fluid analyzers, namely, automated instruments for measuring blood gases, hematocrit, hemoglobin, and electrolytes; medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of disposable cartridges containing reagents for diagnostic testing of bodily fluids in an automated bodily fluid analyzer; medical apparatus and instruments for analysis in laboratories and clinical diagnosis of human diseases in the form of automatic clinical analyzers, namely, electronic instruments for measuring the partial pressure of oxygen and carbon dioxide and ionic activity in the blood | ACTIVE | Jan 1, 2007 |
| 037 | Installation of medical apparatus; Maintenance of medical apparatus; Maintenance of medical devices; Maintenance of medical instruments; Medical apparatus repair | ACTIVE | Jan 1, 2007 |
| 039 | Warehousing; Distribution services, namely, delivery of products, devices and instruments for in vitro diagnostics, and medical devices embedded with clinical data computer applications and software for laboratory information systems, data management for specific clinical applications, integrated solutions for communication, clinical diagnostics and patient-focused systems, therapy management, chronic disorders and telemedicine, medical-surgical products for the hospital sector, scientific, analytical and laboratory instrumentation; Import and export services, namely, transportation of the merchandise of others in the nature of products, apparatus and instruments for in vitro analysis and diagnosis, diagnostic kits consisting of sample receivers and reagents for analyzing selected bacteria, biomolecular labeling kits consisting of reagents for use in scientific research, mixtures of chemical reagents in kit form, other than those for medical or veterinary use, mixtures of chemical reagents, other than for medical or veterinary use, analytical reagents for scientific use, monoclonal antibody reagents for medical use, diagnostic reagents, other than for medical laboratory use, diagnostic reagents for scientific or research use, test reagents, other than those for medical use, test reagents for industrial use, immunoassay reagents, other than those for medical use, laboratory reagents for scientific use, reagents for microbiological analysis other than for medical or veterinary use, reagents for chemical analysis, reagents for research, reagents for medical research, reagents for use in immunoserology, reagents for use in scientific apparatus for chemical or biological analysis, reagents for use with analyzers, other than for medical or veterinary use, diagnostic reagents for medical or veterinary use, immunoassay reagents for medical or veterinary use, medical reagents for clinical use, reagents for clinical analysis for medical or veterinary use, reagents for microbiological analysis for medical or veterinary use, reagents for use in analyzers for medical or veterinary use, reagents for use in in vitro laboratories for medical or veterinary purposes, chemical reagents for medical or veterinary tests, medical devices embedded with software and computer programs for laboratory information systems, data management for specific clinical applications, integrated solutions for communication, clinical diagnostics and patient-focused systems, therapy management, chronic disorders and telemedicine, medical-surgical products for the hospital sector, scientific, analytical and laboratory instrumentation; Transportation of products, devices and instruments for in vitro diagnostics and laboratory information systems, and medical devices embedded with software and computer applications for data management for specific clinical applications, integrated solutions for communication, clinical diagnostics and patient-focused systems, such as therapy management, chronic disorders and telemedicine, medical-surgical products for the hospital sector, scientific, analytical and laboratory instrumentation by domestic transportation means | ACTIVE | Jan 1, 2007 |
| 042 | Engineering services, namely, engineering for the research, design and development of products, devices and instruments for in vitro diagnostics, computer applications and software for laboratory information systems, data management for specific clinical applications, integrated solutions for communication, clinical diagnostics and patient-focused systems, therapy management, chronic disorders and telemedicine, medical-surgical products for the hospital sector, scientific, analytical and laboratory instrumentation; Installation of computer software; Maintenance of computer software; Repair of software; Scientific and technological services, namely, scientific research, design and development of in vitro diagnostic devices and instruments, computer applications and software for laboratory information systems, data management for specific clinical applications, integrated communication solutions, clinical diagnostic and patient-focused systems, such as therapy management, chronic disorders and telemedicine, medical-surgical devices and instruments for the hospital sector, scientific, analytical and laboratory instrumentation in the field of health technologies | ACTIVE | Jan 1, 2007 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by WERFEN S.A.
- Other trademarks owned by WERFENLIFE S.A.
- Other trademarks owned by WERFENLIFE S.A.
- Other trademarks owned by WERFENLIFE S.A.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 037
- Other trademarks in Class 039
- Other trademarks in Class 042
- Similar marks named WERFEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 30, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 28, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 28, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 28, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 25, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 25, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2024 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 5, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 5, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 5, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 5, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 5, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 29, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 29, 2024 | ALIE | ASSIGNED TO LIE | — |
| Oct 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 10, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 10, 2023 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Oct 10, 2023 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Oct 10, 2023 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 7, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jul 7, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 10, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 10, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 10, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2022 | PMSG | PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED | — |
| Aug 24, 2022 | PMSD | PETITION TO DIRECTOR - MAKE SPECIAL - DENIED | — |
| Aug 22, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Jul 27, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 19, 2022 | TPMS | TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED | — |
| Jul 12, 2022 | NWAP | NEW APPLICATION ENTERED | — |